Ammonia Inhalant
NDC Package 55670-710-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ammonia Inhalant is a medication used to treat or prevent fainting. Marketed by Moore Medical Llc, this product is identified by NDC 55670-710.

Identification & Billing

NDC Package Code
55670-710-01
Package Description
100 CAPSULE in 1 BOX / .3 mL in 1 CAPSULE
Product Code
55670-710
11-Digit Billing Format
55670071001

Clinical Specifications

Proprietary Name
Ammonia Inhalant
Dosage Form
-
Usage Information
This product is used to treat or prevent fainting. It works by increasing the body's urge to breathe.

Regulatory & Marketing

Labeler Name
Moore Medical Llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-29-2017
End Marketing Date
01-01-2025
Listing Expiration
01-01-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55670-710-01 identifies a specific commercial package of 100 capsule in 1 box / .3 ml in 1 capsule of Ammonia Inhalant, labeled by Moore Medical Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Moore Medical Llc on November 29, 2017. The current certification is valid through January 01, 2025.

What are the primary indications for this medication?

This product is used to treat or prevent fainting. It works by increasing the body's urge to breathe.

How is this Moore Medical Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55670071001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55670-710-01
11-Digit CMS (5-4-2)
55670-0710-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.